Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
Ruggieri R, Rigo M, Naccarato S, Gurrera D, Figlia V, Mazzola R, Ricchetti F, Nicosia L, Giaj-Levra N, Cuccia F, Vitale C, Stavreva N, Pressyanov DS, Stavrev P, Pellegrini R, Alongi F. Ruggieri R, et al. Among authors: vitale c. Phys Med. 2020 Dec;80:34-41. doi: 10.1016/j.ejmp.2020.09.026. Epub 2020 Oct 20. Phys Med. 2020. PMID: 33091796
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
Alongi F, Rigo M, Figlia V, Cuccia F, Giaj-Levra N, Nicosia L, Ricchetti F, Vitale C, Sicignano G, De Simone A, Naccarato S, Ruggieri R, Mazzola R. Alongi F, et al. Among authors: vitale c. Br J Radiol. 2021 Jan 1;94(1117):20200848. doi: 10.1259/bjr.20200848. Epub 2020 Nov 2. Br J Radiol. 2021. PMID: 33095659 Free PMC article.
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
Mazzola R, Cuccia F, Figlia V, Rigo M, Nicosia L, Giaj-Levra N, Ricchetti F, Vitale C, Mantoan B, Di Paola G, De Simone A, Gurrera D, Sicignano G, Naccarato S, Ruggieri R, Alongi F. Mazzola R, et al. Among authors: vitale c. Radiol Med. 2021 Jul;126(7):989-997. doi: 10.1007/s11547-021-01352-w. Epub 2021 Apr 9. Radiol Med. 2021. PMID: 33835309
The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes.
Cuccia F, Pastorello E, Vitale C, Nicosia L, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Attinà G, Ceccaroni M, Ruggieri R, Alongi F. Cuccia F, et al. Among authors: vitale c. J Cancer Res Clin Oncol. 2021 Dec;147(12):3613-3618. doi: 10.1007/s00432-021-03802-4. Epub 2021 Sep 20. J Cancer Res Clin Oncol. 2021. PMID: 34545423
Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy.
Nicosia L, Mazzola R, Vitale C, Cuccia F, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Ruggeri R, Cavalleri S, Alongi F. Nicosia L, et al. Among authors: vitale c. Radiol Med. 2022 May;127(5):560-570. doi: 10.1007/s11547-022-01479-4. Epub 2022 Mar 26. Radiol Med. 2022. PMID: 35347581
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients.
Alongi F, Rigo M, Figlia V, Nicosia L, Mazzola R, Giaj Levra N, Ricchetti F, Trapani G, Attinà G, Vitale C, Pastorello E, De Simone A, Gurrera D, Naccarato S, Sicignano G, Ruggieri R, Cuccia F. Alongi F, et al. Among authors: vitale c. J Pers Med. 2022 Nov 30;12(12):1982. doi: 10.3390/jpm12121982. J Pers Med. 2022. PMID: 36556203 Free PMC article.
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes.
Mazzola R, Figlia V, Rigo M, Cuccia F, Ricchetti F, Giaj-Levra N, Nicosia L, Vitale C, Sicignano G, De Simone A, Naccarato S, Ruggieri R, Alongi F. Mazzola R, et al. Among authors: vitale c. J Cancer Res Clin Oncol. 2020 Sep;146(9):2379-2397. doi: 10.1007/s00432-020-03230-w. Epub 2020 May 5. J Cancer Res Clin Oncol. 2020. PMID: 32372146
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F, Mazzola R, Nicosia L, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Vitale C, Mantoan B, De Simone A, Sicignano G, Ruggieri R, Cavalleri S, Alongi F. Cuccia F, et al. Among authors: vitale c. Radiat Oncol. 2020 Jul 22;15(1):178. doi: 10.1186/s13014-020-01622-3. Radiat Oncol. 2020. PMID: 32698843 Free PMC article.
718 results